(S)-4-(((1-PROPYL-1H-IMIDAZOL-5-YL)METHYL)SULFINYL)ANILINE, 95.0%, 1g

3,6,9,12-Tetraoxatetradecan-1-ol, 14-amino-, 98%, 25g

3,5-Difluorobenzylamine, 97.0%, 25g

(4,6-DICHLORO-PYRIDIN-2-YL)-METHYL-AMINE, 95.0%, 5g

1-(5-Bromopyrimidin-2-yl)cyclopropanecarboxylic acid, 95.0%, 1g

2-Methyl-N1-(1-methylethyl)-1,2-Propanediamine dihydrochloride, 95%, 100mg

8-Chloro-[1,2,4]triazolo[1,5-a]pyridine, 98%, 250mg

TERT-BUTYL 8-BROMOQUINOLIN-3-YLCARBAMATE, 99.0%, 1g

(R)-3-CBZ-AMINO-3-T-BUTYL-PROPANOIC ACID, 97.0%, 1g

METHYL 4-(1-METHYL-1H-PYRAZOL-5-YL)THIOPHENE-2-CARBOXYLATE, 95.0%, 250mg

Trial kit Spectra/Por® 1-3 Spectra/Por® 2 - MWCO 12,000–14,000, 45 mm, 1 Piece(s)

3-Amino-3-methyloxetane hydrochloride, 97.0%, 25g

6-Aminobenzo[c][1,2]oxaborol-1(3H)-ol, 95.0%, 5g